By accepting, you agree to our updated Terms of Service, including the arbitration provision and class action waiver. You understand that we process your information as described in the Privacy Policy, which may include sharing information about your use of Bloomberg.com with third parties. Accepting does not affect your right to opt-out at any time via the Do Not Sell or Share My Personal Information link in the website footer.
A federal appeals court has revived a whistleblower-led False Claims Act suit alleging AbbVie, AstraZeneca, Novartis and Sanofi overcharged Medicare and Medicaid through 340B “penny pricing” viola...